15 patents
Utility
Formulation for inhibiting formation of 5-HT
17 Oct 23
Drug combinations and their use are disclosed.
Stephen J. Farr, Brooks Boyd
Filed: 19 May 21
Utility
Formulation for inhibiting formation of 5-HT
19 Sep 23
Drug combinations and their use are disclosed.
Stephen J. Farr, Brooks Boyd
Filed: 1 Jul 21
Utility
Fenfluramine compositions and methods of preparing the same
25 Apr 23
Derek J. Londesbrough, Marc W. Andersen
Filed: 27 Jan 21
Utility
Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
28 Mar 23
Provided is a method of treating a patient infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), comprising: determining the patient has been infected with SARS-CoV-2; and administering to the patient a therapeutically effective dose of fenfluramine.
Bradley S. Galer
Filed: 24 Jun 21
Utility
Compositions and methods for treating seizure-induced sudden death
7 Feb 23
5-HT receptor agonists are useful in the treatment of a variety of diseases.
Parthena Martin
Filed: 11 May 18
Utility
Ketogenic diet compatible fenfluramine formulation
4 Oct 22
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient.
Khawla Abu-Izza, David Hickman, Glenn Morrison, Brooks M. Boyd
Filed: 4 May 20
Utility
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
9 Aug 22
Drug combinations and their use are disclosed.
Stephen J. Farr, Brooks Boyd
Filed: 7 Jan 22
Utility
Metabolism resistant fenfluramine analogs and methods of using the same
10 May 22
Metabolism-resistant fenfluramine analogs are provided.
Stephen J. Farr, Brooks M. Boyd
Filed: 8 May 20
Utility
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
22 Jun 21
Drug combinations and their use are disclosed.
Stephen J. Farr, Brooks Boyd
Filed: 6 Mar 20
Utility
Compositions and methods for treating respiratory depression with fenfluramine
23 Mar 21
5-HT receptor agonists are useful in the treatment of a variety of diseases.
Bradley S. Galer, Carl L. Faingold, Parthena Martin
Filed: 22 Nov 19
Utility
Fenfluramine compositions and methods of preparing the same
16 Mar 21
Derek J. Londesbrough, Marc W. Andersen
Filed: 4 Jun 19
Utility
Control system for control of distribution of medication
16 Mar 21
A system of controlling distribution of a medication in the treatment or prevention of epilepsy is provided.
Richard Alistair Balfour Stewart, Anthony Clarke
Filed: 10 Sep 18
Utility
Metabolism resistant fenfluramine analogs and methods of using the same
22 Jun 20
Metabolism-resistant fenfluramine analogs are provided.
Stephan J. Farr, Brooks M. Boyd
Filed: 19 Dec 16
Utility
Ketogenic diet compatible fenfluramine formulation
15 Jun 20
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient.
Khawla Abu-Izza, David Hickman, Glenn Morrison, Brooks M. Boyd
Filed: 23 Sep 18
Utility
Formulation for inhibiting formation of 5-HT
30 Mar 20
Drug combinations and their use are disclosed.
Stephen J. Farr, Brooks Boyd
Filed: 15 Nov 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first